Results 31 to 40 of about 24,935 (185)

Exacerbation of neuropsychiatric symptoms in an adult male with influenza A virus treated with oseltamivir [PDF]

Mental Health Clinician
Oseltamivir (Tamiflu) package labeling has a warning for neuropsychiatric adverse events (NPAE), most commonly in children and adolescents, especially males.
Masa Scott, PharmD, BCPS, BCPP, Emily Faltin, PharmD, MBA, Kathleen Londick, PharmD   +2 more
doaj   +1 more source

Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons [PDF]

Korean Journal of Pediatrics, 2013
PurposeThere was a global increase in the prevalence of oseltamivir-resistant influenza viruses during the 2007-2008 influenza season. This study was conducted to investigate the occurrence and characteristics of oseltamivir-resistant influenza viruses ...
Seoung Geun Kim, Yoon Ha Hwang, Yung Hae Shin, Sung Won Kim, Woo Sik Jung, Sung Mi Kim, Jae Min Oh, Na Young Lee, Mun Ju Kim, Kyung Soon Cho, Yeon Gyeong Park, Sang Kee Min, Chang Kyu Lee, Jun Sub Kim, Chun Kang, Joo Yeon Lee, Man Kyu Huh, Chang Hoon Kim   +17 more
doaj   +1 more source

Efficacy of baloxavir marboxil on household transmission of influenza infection

Journal of Pharmaceutical Health Care and Sciences, 2020
Background Baloxavir marboxil (baloxavir) is a new anti-influenza virus agent that is comparable to oseltamivir phosphate (oseltamivir). Since the efficacy of baloxavir in preventing household transmission of influenza is not well established, we ...
Takumi Umemura, Yoshikazu Mutoh, Takato Kawamura, Masayuki Saito, Takahito Mizuno, Aiko Ota, Koji Kozaki, Tetsuya Yamada, Yoshiaki Ikeda, Toshihiko Ichihara   +9 more
doaj   +1 more source

Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. [PDF]

PLoS Pathogens, 2010
The neuraminidase (NA) inhibitor oseltamivir offers an important immediate option for the control of influenza, and its clinical use has increased substantially during the recent H1N1 pandemic.
Susu Duan, David A Boltz, Patrick Seiler, Jiang Li, Karoline Bragstad, Lars P Nielsen, Richard J Webby, Robert G Webster, Elena A Govorkova   +8 more
doaj   +1 more source

Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan

, 2014
Background: The Taiwan CDC provided free oseltamivir to all patients with influenza infections confirmed by rapid testing or who had clinical warning symptoms during the 2009 H1N1 influenza pandemic in Taiwan.
Liu, Chia-Hung;Wang, Jiun-Ling;Su, Chia-Ping;Chuang, Jen-Hsiang;Chang, Chia-Hsuin;Lai, Mei-Shu, 賴美淑;張家勳   +1 more
core   +1 more source

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom. [PDF]

, 2009
We analyzed data on all laboratory-confirmed cases of H1N1pdm influenza in the UK to 10th June 2009 to estimate epidemiological characteristics. We estimated a mean incubation period of 2.05 days and serial interval of 2.5 days with infectivity peaking ...
Baguelin, M., Truscott, J., Ghani, Azra C, Kafatos, George, Flasche, S., Fraser, C., Barrass, Iain, Tini Garske, Donnelly, C., Jenkins, Helen E., McMenamin, Jim, Ian Hall, Robertson, C., Catchpole, Mike, Hall, Ian M, Charlett, André, Truscott, J, Azra Ghani, James Truscott, Garske, T., Hall, I.; id_orcid, Donnelly, Christl, Fraser, C, Cooper, Ben S., White, Michael, Hawkins, Colin, Griffin, J, Leach, S, Steve Leach, Harris, Ross, Griffin, Jamie T, White, Peter J., Christl Donnelly, Bermingham, Alison, Cooper, Ben S, Ferguson, N, Peter White, Ben Cooper, Jenkins, Helen, Albert Jan van Hoek, Hall, I, Donnelly, Christl A, Michael White, Truscott, James, Jamie Griffin, Ferguson, Neil M., Jenkins, Helen E, Cauchemez, S., Griffin, Jamie, Edmunds, W. John, Baguelin, Marc, Cauchemez, S, Simon Cauchemez, Marc Baguelin, White, Michael T., Garske, Tini, Garske, T, Pebody, Richard, White, Michael T, Cauchemez, Simon, White, Peter, Van Hoek, AJ, Christophe Fraser, Robertson, C, Griffin, J., Ellis, Joanna, Helen Jenkins, Jenkins, H, Donnelly, C, Neil Ferguson, Flasche, S, Ferguson, Neil M, Stefan Flasche, Leach, S., Fraser, Christophe, Cooper, Ben, White, Peter J, van Hoek, Albert Jan, Leach, Steve, Zambon, Maria, van Hoek, A.J., Chris Robertson, Ferguson, Neil, Ghani, Azra, Hall, Ian, Flasche, Stefan, Ghani, A, Phin, Nick, Cooper, B, Baguelin, M, Robertson, Chris, White, M, Ghani, A., White, P   +93 more
core   +1 more source

Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia

ERJ Open Research, 2021
Background The relationship between early oseltamivir treatment (within 48 h of symptom onset) and mortality in patients admitted to intensive care units (ICUs) with severe influenza is disputed.
Gerard Moreno, Alejandro Rodríguez, Jordi Sole-Violán, Ignacio Martín-Loeches, Emili Díaz, María Bodí, Luis F. Reyes, Josep Gómez, Juan Guardiola, Sandra Trefler, Loreto Vidaur, Elisabet Papiol, Lorenzo Socias, Carolina García-Vidal, Eudald Correig, Judith Marín-Corral, Marcos I. Restrepo, Jonathan S. Nguyen-Van-Tam, Antoni Torres   +18 more
doaj   +1 more source

Effectiveness of early oseltamivir treatment in children with pandemic 2009 A/H1N1 influenza in the Vilnius University Children Hospital

Acta Medica Lituanica, 2013
Background. Oseltamivir is recommended for treatment of pandemic influenza in children. The therapy should be started as soon as possible, however, data on the effectiveness of such a treatment is rather limited.
Vytautas Usonis, Irena Narkevičiūtė, Vilija Guntaitė   +2 more
doaj   +1 more source

Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages

International Journal of Health Geographics, 2010
Background In Spring 2009, a novel reassortant strain of H1N1 influenza A emerged as a lineage distinct from seasonal H1N1. On June 11, the World Heath Organization declared a pandemic - the first since 1968. There are currently two main branches of H1N1
Treseder Travis W, Alexandrov Boyan B, Hardman Jori, Studer Jonathon, Voronkin Igor O, Janies Daniel A, Valson Chandni   +6 more
doaj   +1 more source

Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis

Scandinavian Journal of Primary Health Care, 2021
Objective Recovery time and treatment effect of oseltamivir in influenza-like illness (ILI) differs between patient groups. A point-of-care test to better predict ILI duration and identify patients who are most likely to benefit from oseltamivir ...
Nicolay Jonassen Harbin, Karin Rystedt, Morten Lindbaek, Ruta Radzeviciene, Johan Westin, Ronny Gunnarsson, Christopher C. Butler, Alike W. van der Velden, Theo J. Verheij, Pär-Daniel Sundvall   +9 more
doaj   +1 more source